Simulation Model of Ibrutinib in Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL)

Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2196
https://www.valueinhealthjournal.com/article/S1098-3015(14)04126-6/fulltext
Title : Simulation Model of Ibrutinib in Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04126-6&doi=10.1016/j.jval.2014.08.2196
First page : A620
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1652
Categories :
Tags :
Regions :
ViH Article Tags :